The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of Aurora kinase A and B expression on response to neoadjuvant chemotherapy and patient outcome in muscle-invasive bladder cancer (MIBC).
 
Earle Frederick Burgess
Stock and Other Ownership Interests - Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Ignyta; Johnson & Johnson; McKesson; Medtronic; Syndax
Consulting or Advisory Role - Exelixis; Janssen; Takeda
Speakers' Bureau - Exelixis; Janssen; Roche/Genentech
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Exelixis; Roche/Genentech
 
Chad Livasy
No Relationships to Disclose
 
Sally J Trufan
No Relationships to Disclose
 
Aaron Hartman
No Relationships to Disclose
 
Renato Guerrieri
No Relationships to Disclose
 
Caroline Naso
No Relationships to Disclose
 
Peter E Clark
Consulting or Advisory Role - Genentech/Roche
Research Funding - Galil Medical
 
Claud Grigg
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Immatics; Lilly
Research Funding - Bayer (Inst); Celgene (Inst); Novocure (Inst)
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst); Gerson Lehrman Group